Mayron Antonio Candia Puma

Prof. Mayron Antonio Candia Puma

Catholic University of Santa María, Arequipa, Peru
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Mayron Antonio Candia PumaMayron Antonio Candia Puma
Mayron Antonio Candia Puma
LMLaura Yesenia Machaca-Luque
Laura Yesenia Machaca-Luque
BRBrychs Milagros Roque-Pumahuanca
Brychs Milagros Roque-Pumahuanca
ALEXSANDRO SOBREIRA GALDINOALEXSANDRO SOBREIRA GALDINO
ALEXSANDRO SOBREIRA GALDINO
RODOLFO CORDEIRO GIUNCHETTIRODOLFO CORDEIRO GIUNCHETTI
RODOLFO CORDEIRO GIUNCHETTI
Miguel Angel Chavez FumagalliMiguel Angel Chavez Fumagalli
Miguel Angel Chavez Fumagalli
The present systematic review and meta-analysis about the accuracy of diagnostic tests aim to describe the findings of literature over the last thirty years for the diagnosis of Chagas disease (CD). This work aimed to determine the accuracy of diagnostic techniques for CD in the disease’s acute and chronic phases. The PubMed database was searched for studies published between 1990 and 2021 on CD diagnostics. Fifty-six published studies that met the criteria were analyzed and included in the meta-analysis, evaluating diagnostic accuracy through sensitivity and specificity. For Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescent Antibody Technique (IFAT), Hemagglutination Test (HmT), Polymerase Chain Reaction (PCR), and Real-Time Polymerase Chain Reaction (qPCR) diagnosis methods, the sensitivity had a median of 99.0%, 78.0%, 75.0%, 76.0%, and 94.0%, respectively; while specificity presented a median of 99.0%, 99.0%, 99.0%, 98.0%, and 98.0%, respectively. This meta-analysis showed that ELISA and qPCR techniques had a higher performance compared to other methods of diagnosing CD in the chronic and acute phases, respectively. It was concluded utilizing the Area Under the Curve restricted to the false positive rates (AUCFPR), that the ELISA diagnostic test presents the highest performance in diagnosing acute and chronic CD, compared to serological and molecular tests. Future studies focusing on new CD diagnostics approaches should be targeted.

26 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
JVJuan Jeferson Vilca-Alosilla
Juan Jeferson Vilca-Alosilla
Mayron Antonio Candia PumaMayron Antonio Candia Puma
Mayron Antonio Candia Puma
KCKatiusca Coronel-Monje
Katiusca Coronel-Monje
Luis Daniel Goyzueta-MamaniLuis Daniel Goyzueta-Mamani
Luis Daniel Goyzueta-Mamani
ALEXSANDRO SOBREIRA GALDINOALEXSANDRO SOBREIRA GALDINO
ALEXSANDRO SOBREIRA GALDINO
Miguel Angel Chavez FumagalliMiguel Angel Chavez Fumagalli
Miguel Angel Chavez Fumagalli
In this paper, we present a systematic review and meta-analysis that aims to evaluate the reliability of coronavirus disease diagnostic tests in 2019 (COVID-19). This article seeks to describe the scientific discoveries made because of diagnostic tests conducted in recent years during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Between 2020 and 2021, searches for published papers on the COVID-19 diagnostic were made in the PubMed database. Ninety-nine scientific articles that satisfied the requirements were analyzed and included in the meta-analysis, and the specificity and sensitivity of the diagnostic accuracy were assessed. When compared to serological tests such as the enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), lateral flow immunoassay (LFIA), and chemiluminescent microparticle immunoassay (CMIA), molecular tests such as reverse transcription polymerase chain reaction (RT-PCR), reverse transcription loop-mediated isothermal amplification (RT-LAMP), and clustered regularly interspaced short palindromic repeats (CRISPR) performed better in terms of sensitivity and specificity. Additionally, the area under the curve restricted to the false-positive rates (AUCFPR) of 0.984 obtained by the antiviral neutralization bioassay (ANB) diagnostic test revealed significant potential for the identification of COVID-19. It has been established that the various diagnostic tests have been effectively adapted for the detection of SARS-CoV-2; nevertheless, their performance still must be enhanced to contain potential COVID-19 outbreaks, which will also help contain potential infectious agent outbreaks in the future.

24 May 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
Haruna L. Barazorda-CcahuanaHaruna L. Barazorda-Ccahuana
Haruna L. Barazorda-Ccahuana
Luis Daniel Goyzueta-MamaniLuis Daniel Goyzueta-Mamani
Luis Daniel Goyzueta-Mamani
Mayron Antonio Candia PumaMayron Antonio Candia Puma
Mayron Antonio Candia Puma
CFCamila Simões Freitas
Camila Simões Freitas
GTGrasiele de Sousa Vieria Tavares
Grasiele de Sousa Vieria Tavares
Miguel Angel Chavez FumagalliMiguel Angel Chavez Fumagalli
Miguel Angel Chavez Fumagalli
Introduction: Leishmaniasis is a disease with high mortality rates and approximately 1.5 million new cases each year. Despite the new approaches and advances to fight the disease, there are no effective therapies. Methods: Hence, this study aims to screen for natural products' structural analogs as new drug candidates against leishmaniasis. We applied Computer-aided drug design (CADD) approaches, such as virtual screening, molecular docking, molecular dynamics simulation, molecular mechanics–generalized Born surface area (MM–GBSA) binding free estimation, and free energy perturbation (FEP) aiming to select structural analogs from natural products that have shown anti-leishmanial and anti-arginase activities and that could bind selectively against the Leishmania arginase enzyme. Results: The compounds 2H-1-benzopyran, 3,4-dihydro-2-(2-methylphenyl)-(9CI), echioidinin, and malvidin showed good results against arginase targets from three parasite species and negative results for potential toxicities. The echioidinin and malvidin ligands generated interactions in the active center at pH 2.0 conditions by MM-GBSA and FEP methods. Conclusions: This work suggests the potential anti-leishmanial activity of the compounds and thus can be further in vitro and in vivo experimentally validated.

4 November 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
Mayron Antonio Candia PumaMayron Antonio Candia Puma
Mayron Antonio Candia Puma
BRBrychs Milagros Roque-Pumahuanca
Brychs Milagros Roque-Pumahuanca
LMLaura Yesenia Machaca-Luque
Laura Yesenia Machaca-Luque
LPLeydi Pola-Romero
Leydi Pola-Romero
ALEXSANDRO SOBREIRA GALDINOALEXSANDRO SOBREIRA GALDINO
ALEXSANDRO SOBREIRA GALDINO
Miguel Angel Chavez FumagalliMiguel Angel Chavez Fumagalli
Miguel Angel Chavez Fumagalli
Background: Leishmaniasis is a serious global public health challenge. Its accurate diagnosis is essential for guiding treatment but remains complex, often requiring a combination of tests. Methods: We conducted a systematic review and meta-analysis to evaluate the applicability and diagnostic accuracy of molecular and immunological tests for human tegumentary (TL) and visceral leishmaniasis (VL), searching PubMed for studies published between 1990–2021. Results: Among 165 included studies, PCR-based tests showed high accuracy, with area under the curve values (AUCFPR) of 0.919 for TL and 0.965 for VL. For TL, serological tests exhibited median sensitivities of 83.3–88.1% and specificities of 82.0–92.4%. For VL, the direct agglutination test (DAT) and ELISA demonstrated higher sensitivity (93.0–93.8%) than rapid tests (89.1%) or immunofluorescence (82.0%), all with high specificity (95.5–96.9%). DAT performance (AUCFPR = 0.966) was comparable to molecular tests. Conclusions: Molecular tests are highly accurate for diagnosing leishmaniasis. However, their routine implementation in endemic areas is limited by the need for specialized expertise and infrastructure. We advocate for developing diagnostic procedures tailored to each endemic setting, where molecular methods could facilitate early and accurate diagnosis.

30 September 2022
Verified
Report
Closed access
Mayron Antonio Candia PumaMayron Antonio Candia Puma
Mayron Antonio Candia Puma
LMLaura Yesenia Machaca-Luque
Laura Yesenia Machaca-Luque
BRBrychs Milagros Roque-Pumahuanca
Brychs Milagros Roque-Pumahuanca
ALEXSANDRO SOBREIRA GALDINOALEXSANDRO SOBREIRA GALDINO
ALEXSANDRO SOBREIRA GALDINO
RODOLFO CORDEIRO GIUNCHETTIRODOLFO CORDEIRO GIUNCHETTI
RODOLFO CORDEIRO GIUNCHETTI
Miguel Angel Chavez FumagalliMiguel Angel Chavez Fumagalli
Miguel Angel Chavez Fumagalli
Review question / Objective: The objective of the current work is to systematically review and summarize the available literature on the diagnostic accuracy of diagnostic tests for Chagas Disease. Eligibility criteria: The studies were selected in three stages. In the first, non-English language articles, duplicate articles, reviews, and meta-analyses were excluded, only articles published after 1990 and conducted on humans were included. In the second stage, the titles and ab-stracts of the articles selected through the search strategy were examined. Finally, the highly relevant full studies were retrieved and separated from the articles with a title or abstract that did not provide sufficient data to be included.

9 January 2024 in Medicina Clínica y Social
Verified
Journal Article
Open access
PDF file
ATAgueda Muñoz del Carpio Toia
Agueda Muñoz del Carpio Toia
LALuis Alvarez-Ankass
Luis Alvarez-Ankass
JSJohany Sanchez-Guillen
Johany Sanchez-Guillen
MHMartiê Guillén- Huanqui
Martiê Guillén- Huanqui
JZJorge Sánchez- Zegarra
Jorge Sánchez- Zegarra
LRLuis Ramos-Vargas
Luis Ramos-Vargas
Resumen Introducción: La Pandemia COVID-19, ha tenido impactos negativos en la salud física y mental de las personas, así como las medidas adoptadas por los gobiernos, para prevenir el contagio masivo de la población como el confinamiento, el aislamiento social, el trabajo y educación virtual. Dentro de los afectados por estos cambios, se encontrarían los estudiantes universitarios del área de la salud, que además de estudiar en estas condiciones de pandemia, no han podido hacer sus prácticas de los servicios de salud. Esta situación de exposición al aislamiento, podría afectar la salud mental de los jóvenes estudiantes universitarios. Objetivo: determinar los niveles de depresión, ansiedad y estrés en estudiantes universitarios y su relación con variables sociodemográficas y las características del aislamiento social durante la Pandemia COVID-19.. Métodos:  Se realizó un estudio descriptivo, observacional, de corte transversal y cuantitativo, con una muestra de 818 estudiantes universitarios de facultades de ciencias de la salud, mediante el cuestionario autoadministrado DASS-21. Resultados:  Los principales hallazgos fueron: una mayor prevalencia en niveles altos (severos y extremadamente severos) en la ansiedad, alcanzado casi a 4 de cada 10 de los evaluados; por otro lado, en depresión y el estrés, 2 de cada 10 de los evaluados, se encontraron en los niveles mencionados. En relación con las variables sociodemográficas, las relacionadas con el COVID-19 y aislamiento social, se hallaron diferencias estadísticamente significativas con el género (mujeres > varones), el haber tenido COVID-19 (Si > No) y vivir con familiares como antes de la pandemia (Si > No) obtuvieron en promedio mayores puntajes en depresión, ansiedad y estrés. Conclusión: Los estudiantes que presentaron mayor depresión, ansiedad y estrés con una diferencia significativa fueron de género femenino, con antecedentes de haber tenido Covid-19, menor contacto con famiiares y haber cumplido con aislamiento social total